Valuing SF-6Dv2 in Australia Using an International Protocol.
Brendan J MulhernRichard NormanJohn BrazierPublished in: PharmacoEconomics (2021)
The model including the Design 1 data and moderating interaction was chosen for the Australian value set. This allows the SF-6Dv2 to be used in health technology assessment decision making in Australia.